| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/2009 | US7589237 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589220 Inhibitors of the anandamide transporter |
| 09/15/2009 | US7589219 2,5-bis-diamine-[1,4]benzoquinonic derivatives, useful for the treatment of alzheimer's disease, method for preparing them and intermediates of said method |
| 09/15/2009 | US7589214 2-Cyclopentyl-4-(4-phenoxyphenyl)thiazole-5-carboxamide; amidation; oxidation; cyclization; |
| 09/15/2009 | US7589212 {4-[2-(5-methyl-[1,3,4]thiadiazol-2-ylamino)-2-(4-phenylthiazol-2-yl)-ethyl]phenyl}sulfamic acid; anticarcinogenic, antitumor, antidiabrtic agent; angiogenesis inhibitor; sarcoid, syphilis, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis |
| 09/15/2009 | US7589211 polymorphs of zoledronic acid and zoledronate sodium salts; monohydrate form; inhibitor of osteoclastic bone resorption |
| 09/15/2009 | US7589208 Solid dosage of a salt of a 3-quinoline-carboxamide derivative that is storage stable for three years; e.g. lithium or calcium salt of laquinimod |
| 09/15/2009 | US7589206 1-[4-(3-Chloro-phenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-piperidin-1-yl-methanone; analgesic; treats diseases caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor |
| 09/15/2009 | US7589205 phosphodiesterase inhibitor; antiinflammatory agent; 3-thia-10-aza-phenanthrenes and iintermediates 3-(3,4-dialkoxy-phenyl)-tetrahydro-thiopyran-4-one and 3-(3,4-dialkoxy-phenyl)-1,1-dioxo-hexahydro-1-thiopyran-4-ylamine, useful for its preparation |
| 09/15/2009 | US7589202 Substituted pyrazoles |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589199 Substituted piperazines |
| 09/15/2009 | US7589189 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589168 Increasing in vivo concentration of A beta peptide, or biologically active fragments or variants thereof within a patient suffering from angiogenic diseases, conditions, or processes |
| 09/15/2009 | US7589167 ZA loops of bromodomains |
| 09/15/2009 | US7589157 Multi-arm block copolymers as drug delivery vehicles |
| 09/15/2009 | US7589132 Low shrinkage upon polymerization comprises the polymerization product of an oligomer comprising a (meth)acrylate functionality and an epoxy functionality |
| 09/15/2009 | US7589128 Process for preparation of amorphous form of a drug |
| 09/15/2009 | US7589127 Aminoalkylphenols, methods of using and making the same |
| 09/15/2009 | US7589126 Useful as potent and selective activated blood coagulation factor X inhibitors, anticoagulants; for example, ethyl [4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl)benzenesulfonyl-amino]ethyl]-2'-methanesulfonylbiphenyl-3-yloxy]acetate; brain and cardiovascular disorders |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589124 Antiinflammatory agents; antipyretics; analgesics; 2,3-bis(nitroxy)-4-(2-(2-((2-chloro-6-fluorophenyl)amino)5-methylphenyl)acetyloxy)butyl 2-(2-((2-chloro-6-fluorophenyl)amino)5-methylphenyl)acetate; gastrointestinal disorders, wound healing, cardiovascular disorders |
| 09/15/2009 | US7589123 Chemical compounds |
| 09/15/2009 | US7589122 Method for soybean aphid population suppression and monitoring using aphid- and host-plant-associated semiochemical compositions |
| 09/15/2009 | US7589121 Reducing glucose blood concentration and increasing tolerance with unsaponifiable avocado extract |
| 09/15/2009 | US7589120 N-[[4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-thienyl]methyl]-4-(trifluoromethyl)benzenesulfonamide; antagonist properties with regard to CB1 cannabinoid receptors |
| 09/15/2009 | US7589119 Less toxicity; side effects redution; administering substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 09/15/2009 | US7589118 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; death receptor agonist; |
| 09/15/2009 | US7589117 Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 09/15/2009 | US7589116 Biaryl substituted pyrazoles as sodium channel blockers |
| 09/15/2009 | US7589115 2-[5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories |
| 09/15/2009 | US7589114 Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-azetidine-carboxylic acids, esters and amides |
| 09/15/2009 | US7589113 Substituted oxadiazole compounds and their use as opioid receptor ligands |
| 09/15/2009 | US7589112 Methylene urea derivatives |
| 09/15/2009 | US7589111 Antitumor agents; improved efficacy and less toxicity; taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3' and an isopropoxycarbamate substituent at C3'. |
| 09/15/2009 | US7589110 Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
| 09/15/2009 | US7589109 4-{[4-({[(2'-OXOSPIRO[CYCLOPENTANE-1,3'-INDOL]-1'(2'H)-YL)CARBONYL]AMINO}METHYL)PIPERIDIN-1-YL]METHYL}TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; for condition mediated by 5-HT4 agonistic activity; gastroesophageal reflux disease |
| 09/15/2009 | US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors |
| 09/15/2009 | US7589107 Amelioration of vitrectomy-induced cataracts |
| 09/15/2009 | US7589106 Injectable dosage form of aqueous solution including a buffer and optional amino acid at alkaline pH; e.g. argatroban, lactobionic acid, and methionine; free of ethanol, saccharides and sugar alcohols; reducing dosage errors, storage stability |
| 09/15/2009 | US7589105 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 09/15/2009 | US7589104 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; e.g. 10-(8-Methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenoxazine-3-carboxylic acid diethylamide |
| 09/15/2009 | US7589103 Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators |
| 09/15/2009 | US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/15/2009 | US7589101 Compounds and compositions as protein kinase inhibitors |
| 09/15/2009 | US7589100 Non-hygroscopic and powdery amorphous pimecrolimus |
| 09/15/2009 | US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor; |
| 09/15/2009 | US7589098 Controlling cell proliferation; side effect reduction ; anticancer agenst |
| 09/15/2009 | US7589097 Using compounds such as 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine for therapy of Parkinson's disease; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 09/15/2009 | US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 09/15/2009 | US7589095 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589093 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases |
| 09/15/2009 | US7589092 Prodrugs of heteroaryl compounds |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7589090 Urinary tract infections, incontinence; analgesics; bladder diseases; antiinflammatory agents; premenstrual tension; irritable bowel syndrome; chronic obstructive pulmonary disease; respiratory system disorders; gastrointestinal disorders |
| 09/15/2009 | US7589089 Inhibitors for GlyT-1 |
| 09/15/2009 | US7589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods |
| 09/15/2009 | US7589087 [5-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyridin-2-yl]-methyl-[3-(1-methyl-piperidin-4-yl)-propyl]-amine; for diseases related to H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus |
| 09/15/2009 | US7589086 Substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agents |
| 09/15/2009 | US7589085 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity |
| 09/15/2009 | US7589084 Anticancer compositions, and methods of making and using the same |
| 09/15/2009 | US7589083 Compounds and compositions to control abnormal cell growth |
| 09/15/2009 | US7589082 Making a slow release estradiol formulation by exposing particles of estradiol and cholesterol to a low relative humidity, then a solvent-saturated atmosphere of acetone and water, drying and recovering; avoids undesirable hormone imbalances; can be injected monthly; low estradiol dissolution rate (EDR) |
| 09/15/2009 | US7589081 High degree of activity induced by the ligands in the activation of readily available but inert chloroaromatic compounds; large scale use; N-phenyl-2-(di-1-adamantyl-phosphino)pyrrole |
| 09/15/2009 | US7589080 β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 09/15/2009 | US7589079 Used in the manufacture of other forms of beta-L-2'-deoxythymidine (telbivudine); increased solubility, improved bioavailability, ease of chemical processing and/or ease of pharmaceutical formulation; hepatitis B |
| 09/15/2009 | US7589078 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections |
| 09/15/2009 | US7589077 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus |
| 09/15/2009 | US7589076 N-Cyclopropyl 2-{3-[1-(4-nitrophenyloxycarbonyl)-4-piperidinyl]-1-propyn-1-yl}adenosine-5'-uronamide; myocardial perfusion, autoimmune diseases, inflammation, allergic diseases, skin diseases, infectious diseases, wasting diseases, organ transplantation |
| 09/15/2009 | US7589075 e.g., an N6-benzyladenosine-5'-uronamide |
| 09/15/2009 | US7589074 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 09/15/2009 | US7589072 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent |
| 09/15/2009 | US7589070 Surface modification for improving biocompatibility |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7589068 Inhibitors of Akt activity |
| 09/15/2009 | US7589067 6, 11-bridged tricyclic macrolides |
| 09/15/2009 | US7589065 Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds |
| 09/15/2009 | US7589064 Formulations of ramipril |
| 09/15/2009 | US7589057 Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems |
| 09/15/2009 | US7589056 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 09/15/2009 | US7588787 Medicated production for local use based on natural materials |
| 09/15/2009 | US7588786 Polyoxyl 35 castor oil; medium chain mono- and diglycerides, an essential oil, and a (poorly soluble) drug such as ubiquinone; capsules, solid dosage forms |
| 09/15/2009 | US7588785 Methods and kits for reducing cellular damage, inhibiting free radical production and scavenging free radicals |
| 09/15/2009 | US7588781 oral administering a mixture powders comprising a dissolved whey protein to increase release the bioactive carotenoid, polyphenol, vitamins, flavonoid, isoflavone, ceramide |
| 09/15/2009 | US7588779 time-release dosage forms contains antihyperglycemic drug metformin and angiotensin antagonist selected from the group consisting of valsartan, losartan, candesartan, eprosartan, irbesartan, olmesartan, tasosartan, and telmisartan |
| 09/15/2009 | US7588778 Delivery carrier for targeting to cells expressed with somatostatin receptors |
| 09/15/2009 | US7588774 Molecules enhancing dermal delivery of influenza vaccines |
| 09/15/2009 | US7588772 adeno-associated viral capsid proteins are generated by gene expressing from a genetic engineered vector; high transduction efficiency and low level of neutralization by the human immune system |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | US7588758 A genetic vector comprising a promoter linked to an expression cassette able to express a cyclooxygenase protein; treating bone disorder osteoporosis, heterotopic ossification |
| 09/15/2009 | US7588757 Methods of treating Parkinson's disease using recombinant adeno-associated virus virions |
| 09/15/2009 | US7588756 Administering intracoronally a compatible auxiliary or support and a nucleic acid encoding a polypeptide S100A1 protein; increases the systolic Ca2+ release from the sarcoplasmic reticulum and increases the rate of Ca2+ uptake into the sarcoplasmic reticulum |
| 09/15/2009 | US7588754 Biodegradable polyacetals and methods |
| 09/15/2009 | US7588753 Synergistically pro-penetrating solutions for ungual/peri-ungual dermatological/cosmetic applications |
| 09/15/2009 | CA2616765C Control of parasitic infestations in farmed and wild fish |
| 09/15/2009 | CA2533784C Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |